Cargando…

Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer

OBJECTIVE: The severity of breakthrough cancer pain (BTcP) impacts patients’ quality of life, increases the risk of anxiety and depression, lowers functional capacities, and may lead to poor compliance with cancer treatments. The aim of the current study was to assess, in a real-life setting, patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pointreau, Yoann, Bensadoun, Rene-Jean, Bera, Guillaume, Sire, Christian, Ruffier, Amandine, Janoray, Guillaume, Calais, Gilles, Bollet, Marc, Pinel, Baptiste, Braniste, Viorica, Amores, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247611/ https://www.ncbi.nlm.nih.gov/pubmed/32546980 http://dx.doi.org/10.2147/PPA.S246757

Ejemplares similares

Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain
por: Ueberall, Michael A, et al.
Publicado: (2016)

Fentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients
por: Zeppetella, Giovambattista
Publicado: (2013)

Single-dose fentanyl sublingual spray for breakthrough cancer pain
por: Taylor, Donald R
Publicado: (2013)

Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation
por: Lemaire, Antoine, et al.
Publicado: (2021)

Correction to: Effectiveness of naloxegol in patients with cancer pain suffering from opioid‑induced constipation
por: Lemaire, Antoine, et al.
Publicado: (2021)

Management of predictable pain using fentanyl pectin nasal spray in patients undergoing radiotherapy
por: Bell, Brent C, et al.
Publicado: (2013)

Stereotactic Re-Irradiation for Local Recurrence after Radical Prostatectomy and Radiation Therapy: A Retrospective Multicenter Study
por: Perennec, Tanguy, et al.
Publicado: (2021)

Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial
por: Legouté, Florence, et al.
Publicado: (2019)

Role of intranasal fentanyl in breakthrough pain management in cancer patients
por: Leppert, Wojciech
Publicado: (2010)

Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
por: Prommer, Eric, et al.
Publicado: (2012)

Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain
por: Darbà, Josep, et al.
Publicado: (2013)

Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment
por: Cortesi, Paolo Angelo, et al.
Publicado: (2017)

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
por: Rogé, Maximilien, et al.
Publicado: (2023)

Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets
por: Guitart, Jordi, et al.
Publicado: (2019)

Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery
por: Valtola, Antti, et al.
Publicado: (2021)

Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
por: Freye, Enno
Publicado: (2008)

Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis
por: Janknegt, Robert, et al.
Publicado: (2018)

Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Comparison of analgesia, adverse effects, and quality of life in cancer patients during treatment of procedural pain with intravenous morphine, fentanyl nasal spray, and fentanyl buccal tablets
por: Piotrowska, Wieslawa, et al.
Publicado: (2019)

Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS
por: Masel, Eva Katharina, et al.
Publicado: (2017)

Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study
por: Guitart, Jordi, et al.
Publicado: (2017)

Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study
por: Rauck, R., et al.
Publicado: (2010)

Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain
por: Bhatnagar, Sushma, et al.
Publicado: (2014)

Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain: Pharmacokinetics of Buccal Mucosa Delivery and Clinical Efficacy
por: Darwish, Mona, et al.
Publicado: (2010)

New photobiomodulation device for prevention and cure of radiotherapy-induced oral mucositis and dermatitis: results of the prospective Safe PBM study
por: Bensadoun, René-Jean, et al.
Publicado: (2021)

Hemodynamic Responses to Tracheal Intubation in Elderly Patients: Intravenous or Spray of Lidocaine versus Fentanyl
por: Jalali, Alireza, et al.
Publicado: (2017)

Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness
por: Janssen, Daisy J.A., et al.
Publicado: (2019)

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation with Pre Induction IV Fentanyl Versus Combination of IV Fentanyl and Sub Lingual Nitroglycerin Spray
por: Channaiah, Vijayalakshmi B., et al.
Publicado: (2014)

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007)

An Evaluation of Total Disintegration Time for Three Different Doses of Sublingual Fentanyl Tablets in Patients with Breakthrough Pain
por: Nalamachu, Srinivas
Publicado: (2013)

A Rare Case of Radiation-Induced Osteosarcoma of the Ethmoid Sinus
por: Alzahrani, Musaed, et al.
Publicado: (2011)

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study
por: Cuomo, Arturo, et al.
Publicado: (2020)

A new innovative breakthrough in the production of salt from bittern using a spray dryer
por: Ansar, Ansar, et al.
Publicado: (2022)

Microencapsulation of Curcumin in Crosslinked Jelly Fig Pectin Using Vacuum Spray Drying Technique for Effective Drug Delivery
por: Hartini, Nina, et al.
Publicado: (2021)

Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: A randomized controlled trial
por: Banala, Srinivas R., et al.
Publicado: (2020)

Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl
por: Kuip, Evelien J.M., et al.
Publicado: (2018)

Theophylline-Loaded Pectin/Chitosan Hydrochloride Submicron Particles Prepared by Spray Drying with a Continuous Feeding Ultrasonic Atomizer
por: Cheng, Kuo-Chung, et al.
Publicado: (2022)

Pectins and Olive Pectins: From Biotechnology to Human Health
por: Millan-Linares, Maria C., et al.
Publicado: (2021)

Management of breakthrough pain in children with cancer
por: Friedrichsdorf, Stefan J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nhbjbujvtp5gc0lokrshtnng5i